Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-16-142120
Filing Date
2016-08-30
Accepted
2016-08-30 17:05:20
Documents
2
Group Members
NOVARTIS PHARMA AG

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a16-17495_1sc13da.htm SC 13D/A 196276
2 EX-1 a16-17495_1ex1.htm EX-1 17307
  Complete submission text file 0001104659-16-142120.txt   215131
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Subject) CIK: 0001235010 (see all company filings)

EIN.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79927 | Film No.: 161861254
SIC: 2836 Biological Products, (No Diagnostic Substances)